PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50 Hold
5
﹤0.01% 535
2026
Q1
$31 Hold
5
﹤0.01% 510
2025
Q4
$42 Hold
5
﹤0.01% 526
2025
Q3
$73 Hold
5
﹤0.01% 529
2025
Q2
$56 Hold
5
﹤0.01% 489
2025
Q1
$29 Hold
5
﹤0.01% 475
2024
Q4
$49 Hold
5
﹤0.01% 469
2024
Q3
$41 Hold
5
﹤0.01% 373
2024
Q2
$67 Buy
+5
New +$149 ﹤0.01% 355

Other funds holding DNA

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s DNA Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. held its Ginkgo Bioworks (DNA) position steady in Q2 2026 at 5 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #535.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in DNA in Q2 2024 and has held it in 9 quarters since. The position peaked at $73 in Q3 2025. 67 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. held 5 shares of Ginkgo Bioworks worth $50 as of Q2 2026.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. left its Ginkgo Bioworks share count unchanged in Q2 2026.
  • Ginkgo Bioworks made up ﹤0.01% of PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s portfolio in Q2 2026, its #535 holding.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in Ginkgo Bioworks in Q2 2024 and has held it in 9 quarters since.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s Ginkgo Bioworks position peaked at $73 in Q3 2025.
  • 67 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.